COX-2 inhibitors and the risk for cardiovascular events: a re-evaluation of the data and proposed mechanisms.
Kusmak
Jacob M
JM
D000208:Acute Disease; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000494:pharmacology; D003627:Data Interpretation, Statistical; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D012307:Risk Factors
D052246:Cyclooxygenase 2 Inhibitors